Term name | Description | FDR value |
---|---|---|
hsa04151 | PI3K-Akt signaling pathway | 8.45E−20 |
hsa05200 | Pathways in cancer | 1.16E−18 |
hsa05418 | Fluid shear stress and atherosclerosis | 1.97E−17 |
hsa05206 | MicroRNAs in cancer | 1.67E−16 |
hsa04015 | Rap1 signaling pathway | 3.74E−15 |
hsa04068 | FoxO signaling pathway | 7.0E−15 |
hsa04010 | MAPK signaling pathway | 7.58E−15 |
hsa05205 | Proteoglycans in cancer | 9.21E−15 |
hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.09E−14 |
hsa04510 | Focal adhesion | 7.24E−14 |
hsa05215 | Prostate cancer | 2.77E−13 |
hsa05163 | Human cytomegalovirus infection | 5.07E−13 |
hsa04931 | Insulin resistance | 1.42E−12 |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.2E−12 |
hsa04080 | Neuroactive ligand-receptor interaction | 4.24E−12 |
hsa04668 | TNF signaling pathway | 2.29E−11 |
hsa04211 | Longevity regulating pathway | 4.4E−10 |